Your Messages Inbox
Your Article Summary
See Latest ArticlesU.S. FDA Licenses Sanofi Pasteurs New Influenza Vaccine Manufacturing Facility
Sanofi-aventis, 05/08/09
Sanofi Pasteur, the vaccines division of sanofi-aventis Group , announced today that the U.S. Food and Drug Administration has licensed its new influenza vaccine manufacturing facility. This new facility, located in Swiftwater, Pennsylvania, will incorporate the latest technology in egg-based vaccine production as part of the company's commitment to produce the largest number of doses of vaccine in the shortest time frame to adress the threat of seasonal and pandemic influenza.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Gen-Probe, 10/30/09
Gyrus PlasmaKinetic bipolar coagulation device for liver resection
Australian and New Zealand Journal of Surgery, 11/13/09
Article Search
Sponsor